[Clinical aspects of control in therapy with platelet inhibitors]

I N Bokarev; L V Ovcinnikova; N A Aleksandrova; E V Kabaeva; E V Marcukova; I S Kun; L I Olbinskaja

[Clinical aspects of control in therapy with platelet inhibitors]

Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(5-6):776-82.

[Article in German]

Authors

I N Bokarev, L V Ovcinnikova, N A Aleksandrova, E V Kabaeva, E V Marcukova, I S Kun, L I Olbinskaja

PMID: 94869

Abstract

46 patients with ischaemic heart disease were treated with Micristin (20-40 mg/kg) or a combination of Micristin and Propranolol (80-120 mg/die). The values of bleeding time, the platelet factor 4 in lysate of thrombocytes or in plasma of patients as well as the soluble fibrin monomer complexes were investigated. They showed no obvious correlation to the clinical findings.

Publication types

English Abstract

MeSH terms

Adenosine Diphosphate
Aspirin / therapeutic use*
Blood Coagulation Tests
Blood Platelets / drug effects*
Coronary Disease / drug therapy*
Fibrin / analysis
Humans
Platelet Adhesiveness / drug effects
Platelet Aggregation / drug effects
Platelet Factor 4 / analysis
Propranolol / therapeutic use

Substances

Platelet Factor 4
Adenosine Diphosphate
Fibrin
Propranolol
Aspirin